United States

People: Eli Lilly and Co (LLY.N)

LLY.N on New York Stock Exchange

4:00pm EDT
Change (% chg)

$-0.73 (-0.94%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Kaelin, William 

Dr. William G. Kaelin Jr., M.D., is Independent Director of the Company. He is a prominent medical researcher and academician. He has extensive experience at Harvard Medical School, a major medical institution, as well as special expertise in oncology—a key component of Lilly's business. He also has deep expertise in basic science, including mechanisms of drug action, and experience with pharmaceutical discovery research.

Basic Compensation

Total Annual Compensation, USD 134,000
Restricted Stock Awards, USD 160,000
Long-Term Incentive Plans, USD --
All Other, USD 20,500
Fiscal Year Total, USD 314,500

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --